List of Excipients in API spironolactone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing spironolactone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | CALCIUM SULFATE DIHYDRATE | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | CARNAUBA WAX | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing spironolactone
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 | CALCIUM SULFATE DIHYDRATE |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 | CROSCARMELLOSE SODIUM |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 | CROSPOVIDONE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for spironolactone
Excipient focus: ALUMINUM OXIDE
spironolactone drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | spironolactone and hydrochlorothiazide | 53489-144 |
| Bryant Ranch Prepack | spironolactone and hydrochlorothiazide | 63629-1068 |
| Bryant Ranch Prepack | spironolactone and hydrochlorothiazide | 63629-1069 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIUM GLYCYRRHIZATE
spironolactone drug variants containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
spironolactone drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
spironolactone drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | spironolactone | 31722-094 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
spironolactone drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | spironolactone | 16714-084 |
| Rebel Distributors Corp | spironolactone | 21695-766 |
| A-S Medication Solutions | spironolactone | 50090-0136 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM SULFATE
spironolactone drug variants containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM SULFATE DIHYDRATE
spironolactone drug variants containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
spironolactone drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | spironolactone | 31722-691 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
spironolactone drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| A-S Medication Solutions | spironolactone | 50090-6408 |
| A-S Medication Solutions | spironolactone | 50090-6432 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
spironolactone drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| Major Pharmaceuticals | spironolactone | 0904-6927 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
spironolactone drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| Major Pharmaceuticals | spironolactone | 0904-6927 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
spironolactone drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| Rebel Distributors Corp | spironolactone | 21695-766 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
spironolactone drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-1292 |
| RPK Pharmaceuticals Inc | spironolactone | 53002-1707 |
| Preferred Pharmaceuticals Inc | spironolactone | 68788-7258 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
spironolactone drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
spironolactone drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | spironolactone | 42254-183 |
| State of Florida DOH Central Pharmacy | spironolactone | 53808-0796 |
| Physicians Total Care Inc | spironolactone | 54868-0700 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
spironolactone drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8221 |
| NorthStar RxLLC | spironolactone | 16714-637 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
spironolactone drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: DOCUSATE SODIUM
spironolactone drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | spironolactone | 16714-084 |
| Rebel Distributors Corp | spironolactone | 21695-766 |
| A-S Medication Solutions | spironolactone | 50090-0136 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
spironolactone drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-1292 |
| RPK Pharmaceuticals Inc | spironolactone | 53002-1707 |
| Preferred Pharmaceuticals Inc | spironolactone | 68788-7258 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
spironolactone drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8221 |
| QPharma Inc | spironolactone | 42708-101 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
spironolactone drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8221 |
| NorthStar RxLLC | spironolactone | 16714-637 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
spironolactone drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| QPharma Inc | spironolactone | 42708-101 |
| Aidarex Pharmaceuticals LLC | spironolactone | 53217-240 |
| Jubilant Cadista Pharmacuticals Inc | spironolactone | 59746-216 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
spironolactone drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
spironolactone drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
spironolactone drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | spironolactone | 0904-6927 |
| A-S Medication Solutions | spironolactone | 50090-3580 |
| A-S Medication Solutions | spironolactone | 50090-3747 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
spironolactone drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Camber Pharmaceuticals Inc | spironolactone | 31722-094 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
spironolactone drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
spironolactone drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
spironolactone drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
spironolactone drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALIC ACID
spironolactone drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| Camber Pharmaceuticals Inc | spironolactone | 31722-691 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
spironolactone drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | spironolactone | 42254-183 |
| State of Florida DOH Central Pharmacy | spironolactone | 53808-0796 |
| Physicians Total Care Inc | spironolactone | 54868-0700 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
spironolactone drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
spironolactone drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-6369 |
| A-S Medication Solutions | spironolactone | 50090-6458 |
| A-S Medication Solutions | spironolactone | 50090-6539 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
spironolactone drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINT
spironolactone drug variants containing MINT
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-6369 |
| A-S Medication Solutions | spironolactone | 50090-6458 |
| A-S Medication Solutions | spironolactone | 50090-6539 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MINT
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT
spironolactone drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| Blenheim Pharmacal Inc | spironolactone | 10544-499 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
spironolactone drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8221 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
spironolactone drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| Blenheim Pharmacal Inc | spironolactone | 10544-499 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
spironolactone drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | spironolactone | 0603-5763 |
| Rebel Distributors Corp | spironolactone | 21695-960 |
| QPharma Inc | spironolactone | 42708-101 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3000
spironolactone drug variants containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-1292 |
| RPK Pharmaceuticals Inc | spironolactone | 53002-1707 |
| Preferred Pharmaceuticals Inc | spironolactone | 68788-7258 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
spironolactone drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | spironolactone | 71335-0966 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
spironolactone drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
spironolactone drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | spironolactone | 0904-6927 |
| Camber Pharmaceuticals Inc | spironolactone | 31722-094 |
| Northwind Pharmaceuticals LLC | spironolactone | 51655-153 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
spironolactone drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Blenheim Pharmacal Inc | spironolactone | 10544-499 |
| Blenheim Pharmacal Inc | spironolactone | 10544-523 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
spironolactone drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| Aidarex Pharmaceuticals LLC | spironolactone | 33261-869 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
spironolactone drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8451 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
spironolactone drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-1292 |
| RPK Pharmaceuticals Inc | spironolactone | 53002-1707 |
| Preferred Pharmaceuticals Inc | spironolactone | 68788-7258 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
spironolactone drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
spironolactone drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NorthStar Rx LLC | spironolactone | 16714-084 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
spironolactone drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8221 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8451 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K29/32
spironolactone drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | spironolactone | 68151-2776 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
spironolactone drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Major Pharmaceuticals | spironolactone | 0904-6927 |
| Camber Pharmaceuticals Inc | spironolactone | 31722-094 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
spironolactone drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| Blenheim Pharmacal Inc | spironolactone | 10544-499 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
spironolactone drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | spironolactone | 31722-691 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
spironolactone drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
spironolactone drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
spironolactone drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | spironolactone | 16714-084 |
| Rebel Distributors Corp | spironolactone | 21695-766 |
| A-S Medication Solutions | spironolactone | 50090-0136 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
spironolactone drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| Major Pharmaceuticals | spironolactone | 0904-6927 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
spironolactone drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | spironolactone | 31722-691 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
spironolactone drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| NorthStar Rx LLC | spironolactone | 16714-084 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
spironolactone drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
spironolactone drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| NorthStar Rx LLC | spironolactone | 16714-084 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
spironolactone drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Greenstone LLC | spironolactone | 59762-5011 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
spironolactone drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-8031 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8178 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
spironolactone drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8451 |
| NCS HealthCare of KY LLC dba Vangard Labs | spironolactone | 0615-8452 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRAGACANTH
spironolactone drug variants containing TRAGACANTH
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TRAGACANTH
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
spironolactone drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| NCS HealthCare of KY Inc dba Vangard Labs | spironolactone | 0615-1535 |
| Blenheim Pharmacal Inc | spironolactone | 10544-499 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Padagis US LLC | spironolactone | 0574-1133 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
spironolactone drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
spironolactone drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-2028 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
spironolactone drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| ATLANTIC BIOLOGICALS CORP | spironolactone | 17856-1133 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
